Literature DB >> 19421784

Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease.

Daryl M Okamura1, Jonathan Himmelfarb.   

Abstract

Patients with moderate to advanced chronic kidney disease or end-stage renal disease have a greatly increased cardiovascular risk that cannot be explained entirely by traditional cardiovascular risk factors. An increase in oxidative stress and inflammation have been proposed as nontraditional cardiovascular risk factors in this patient population. Oxidative stress reflects the redox balance between oxidant generation and antioxidant mechanisms. The generation of reactive oxygen species is not simply a random process that oxidizes nearby macromolecules, but, in many instances, the oxidants target particular amino acid residues or lipid moieties. Oxidant mechanisms are now recognized to be intimately involved in cell signaling and to be vital components of the immune response. This is equally true for antioxidant mechanisms as well. In the progression of chronic kidney disease, the redox balance is not in equilibrium and is tipped toward oxidation, resulting in the dysregulation of cellular process and subsequent tissue injury. In this review we discuss the major oxidant and antioxidant pathways and the biomarkers to assess redox status. We also review the data linking the pathogenesis of oxidative stress, inflammation, and the progressive loss of kidney function in chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421784     DOI: 10.1007/s00467-009-1199-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  124 in total

Review 1.  Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations.

Authors:  Margaret M Tarpey; David A Wink; Matthew B Grisham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-03       Impact factor: 3.619

Review 2.  The Nox family of NAD(P)H oxidases: host defense and beyond.

Authors:  Miklós Geiszt; Thomas L Leto
Journal:  J Biol Chem       Date:  2004-09-13       Impact factor: 5.157

3.  CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD.

Authors:  Daryl M Okamura; Subramaniam Pennathur; Katie Pasichnyk; Jesús M López-Guisa; Sarah Collins; Maria Febbraio; Jay Heinecke; Allison A Eddy
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

4.  Glutathione restores collagen degradation in TGF-beta-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen.

Authors:  Praveen K Vayalil; Mitchell Olman; Joanne E Murphy-Ullrich; Edward M Postlethwait; Rui-Ming Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-10-28       Impact factor: 5.464

5.  Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C.

Authors:  D Boscoboinik; A Szewczyk; C Hensey; A Azzi
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

6.  Differential oxidation of protein-tyrosine phosphatases.

Authors:  Arnoud Groen; Simone Lemeer; Thea van der Wijk; John Overvoorde; Albert J R Heck; Arne Ostman; David Barford; Monique Slijper; Jeroen den Hertog
Journal:  J Biol Chem       Date:  2004-12-28       Impact factor: 5.157

7.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

8.  The redox state of the cell regulates the ligand binding affinity of human neuroglobin and cytoglobin.

Authors:  Djemel Hamdane; Laurent Kiger; Sylvia Dewilde; Brian N Green; Alessandra Pesce; Julien Uzan; Thorsten Burmester; Thomas Hankeln; Martino Bolognesi; Luc Moens; Michael C Marden
Journal:  J Biol Chem       Date:  2003-10-06       Impact factor: 5.157

9.  Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium.

Authors:  Stefan Porubsky; Holger Schmid; Mahnaz Bonrouhi; Matthias Kretzler; Ernst Malle; Peter J Nelson; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

Review 10.  Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation.

Authors:  Pietro Ghezzi; Valentina Bonetto; Maddalena Fratelli
Journal:  Antioxid Redox Signal       Date:  2005 Jul-Aug       Impact factor: 8.401

View more
  33 in total

Review 1.  How Do Kidneys Adapt to a Deficit or Loss in Nephron Number?

Authors:  Hadi Fattah; Anita Layton; Volker Vallon
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Hyperpolarized 13 C magnetic resonance evaluation of renal ischemia reperfusion injury in a murine model.

Authors:  Celine Baligand; Hecong Qin; Aisha True-Yasaki; Jeremy W Gordon; Cornelius von Morze; Justin Delos Santos; David M Wilson; Robert Raffai; Patrick M Cowley; Anthony J Baker; John Kurhanewicz; David H Lovett; Zhen Jane Wang
Journal:  NMR Biomed       Date:  2017-07-14       Impact factor: 4.044

3.  Association between clinical risk factors and progression of chronic kidney disease in children.

Authors:  Amy O Staples; Larry A Greenbaum; Jodi M Smith; Debbie S Gipson; Guido Filler; Bradley A Warady; Karen Martz; Craig S Wong
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 8.237

4.  Adiponectin protects against hyperoxic lung injury and vascular leak.

Authors:  Sean M Sliman; Rishi B Patel; Jason P Cruff; Sainath R Kotha; Christie A Newland; Carrie A Schrader; Shariq I Sherwani; Travis O Gurney; Ulysses J Magalang; Narasimham L Parinandi
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

5.  Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD.

Authors:  Daryl M Okamura; Nadia M Bahrami; Shuyu Ren; Katie Pasichnyk; Juliana M Williams; Jon A Gangoiti; Jesus M Lopez-Guisa; Ikuyo Yamaguchi; Bruce A Barshop; Jeremy S Duffield; Allison A Eddy
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

Review 6.  Bone marrow cell therapies for endothelial repair and their relevance to kidney disease.

Authors:  Darren A Yuen; Richard E Gilbert; Philip A Marsden
Journal:  Semin Nephrol       Date:  2012-03       Impact factor: 5.299

Review 7.  Redox regulation in cancer: a double-edged sword with therapeutic potential.

Authors:  Asha Acharya; Ila Das; Des Chandhok; Tapas Saha
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

8.  Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse.

Authors:  Phyllis Chew; Derek Y C Yuen; Nada Stefanovic; Josefa Pete; Melinda T Coughlan; Karin A Jandeleit-Dahm; Merlin C Thomas; Franklin Rosenfeldt; Mark E Cooper; Judy B de Haan
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

Review 9.  Remnant nephron physiology and the progression of chronic kidney disease.

Authors:  H William Schnaper
Journal:  Pediatr Nephrol       Date:  2013-05-29       Impact factor: 3.714

Review 10.  Risk factors for progression of chronic kidney disease.

Authors:  Amy Staples; Craig Wong
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.